CHICAGO (Reuters) - Pathway Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, on Thursday will launch a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49b91ce0/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C10A0Cus0Egenomics0Epathway0Ebiopsy0EidUSKCN0ARA0ANU20A150A910A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
No comments:
Post a Comment